Can Liposomal CBD Injection Help Dogs With Polyarthritis? Innocan Pharma Reports Clinical Success

Innocan Pharma Corporation INNPF INNO IP reported clinical success in its Canine (dogs) Compassionate Care Trial, resulting in improving walking abilities and significant decrease in pain in participating canines.

"Lady", an 11-year-old spayed dachshund-mixed dog was suffering from severe autoimmune mediated polyarthritis that resulted in an almost complete inability to walk, accompanied by severe pain and an overall disability.

Lady was treated with joint supplements (Glycoflex), steroids, and hydrotherapy, but was still very lame and incapable of walking more than a few steps. In December 2022, as part of the company's Compassionate Care Trial, Lady was administered Innocan's liposomal CBD injection, in addition to all other treatments. Following injection, Lady demonstrated noticeable improvement, walking longer distances and much faster than she had been previously. The improvement in Lady's condition lasted for more than five weeks, indicating the long-acting nature of the liposomal CBD formulation.

"We couldn't be more thrilled than to be able to assist a poor creature in pain," stated CEO Iris Bincovich, "2023 started with rapid clinical and IP performance, igniting the hope that we are getting closer to advanced availability of treatments. We believe that our ability to help Lady will also contribute to our ability to bring CBD-based pharma solutions to the market."

Benzinga's Cannabis Capital Conference Is Back

The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.

Photo by Diyahna Lewis on Unsplash